An international team of transplant physicians has shown that the investigational drug belatacept (LEA29Y) preserves transplanted kidney function as effectively as cyclosporine, the drug most commonly used to prevent the immune system from rejecting transplanted organs. At the same time, belatacept avoids many of the toxic side effects that adversely affect kidney function, blood pressure and cholesterol levels of patients undergoing long-term anti-rejection therapy with immunosuppressant drugs.
The findings from a Phase II clinical trial of belatacept, conducted in 218 patients at 22 centers in the U.S., Canada and Europe between March 2001 and December 2003, are published in the August 25 issue of the New England Journal of Medicine. Christian P. Larsen, MD, PhD, director of the Emory Transplant Center and professor of surgery at Emory University School of Medicine, and Flavio Vincenti, MD, of the University of California, San Francisco, are co-lead authors of the article.
"The results of this study on the safety and effectiveness of belatacept were as good as we could hope for from the first trial of this new class of drugs in human transplant recipients," Dr. Larsen said. "This arguably is among the most important new classes of immunosuppressive drugs to be evaluated since cyclosporine was introduced more than 20 years ago."
Holly Korschun | EurekAlert!
Immune Defense Without Collateral Damage
23.01.2017 | Universität Basel
The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education
For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.
According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
23.01.2017 | Health and Medicine
23.01.2017 | Physics and Astronomy
23.01.2017 | Process Engineering